• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用四氯化碳建立实验性肝纤维化疾病动物模型

Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride.

作者信息

Gitiara Atoosa, Tokhanbigli Samaneh, Mazhari Sogol, Baghaei Kaveh, Hatami Behzad, Hashemi Seyed Mahmoud, Asadi Rad Ali, Moradi Afshin, Nasiri Meyam, Zarrabi Ahrabi Nakisa, Zali Mohammad Reza

机构信息

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S122-S128.

PMID:29511482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5838191/
Abstract

AIM

This study is presenting an effective method of inducing liver fibrosis by CCL4 as a toxin in two different breeds of rat models.

BACKGROUND

Liver fibrosis is a result of inflammation and liver injury caused by wound healing responses which ultimately lead to liver failure. Consequently, after liver fibrosis, the progression will be continued to liver cirrhosis and at the end stage hepatocellular carcinoma (HCC). Many studies have demonstrated that one of the most important causes of liver fibrosis is Non-alcoholic steatohepatitis (NASH). Fibrotic Liver is affected by an excessive accumulation of extracellular matrix (ECM) proteins like collagen and α-SMA.

METHODS

In two different experiments, male Vistar, and Sprague Dawley Rat models ranging from 200±60, corresponding to an age of approximately 10 weeks were utilized in order to induce CCL4 treated liver fibrosis.

RESULTS

After 6 weeks of CCL4 injection, different tests have been carried out to verify the liver fibrosis including serum markers such as Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT), molecular tests containing, laminin and α-SMA and also pathological observation by Hematoxylin and eosin staining in both fibrosis and control group.

CONCLUSION

The results of Pathology and Real-time PCR showed that fibrosis was induced much more effectively in Sprague Dawley rat model compared with Wistar rats.

摘要

目的

本研究提出了一种在两种不同品系大鼠模型中用四氯化碳作为毒素诱导肝纤维化的有效方法。

背景

肝纤维化是伤口愈合反应引起的炎症和肝损伤的结果,最终导致肝衰竭。因此,肝纤维化后,病情会继续发展为肝硬化,最终发展为肝细胞癌(HCC)。许多研究表明,肝纤维化最重要的原因之一是非酒精性脂肪性肝炎(NASH)。纤维化肝脏受到胶原蛋白和α-SMA等细胞外基质(ECM)蛋白过度积累的影响。

方法

在两个不同的实验中,使用体重200±60克、年龄约10周的雄性维斯塔大鼠和斯普拉格-道利大鼠模型来诱导四氯化碳处理的肝纤维化。

结果

在注射四氯化碳6周后,进行了不同的测试以验证肝纤维化,包括血清标志物如天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)、分子测试包括层粘连蛋白和α-SMA,以及在纤维化组和对照组中通过苏木精和伊红染色进行病理观察。

结论

病理学和实时PCR结果表明,与维斯塔大鼠相比,斯普拉格-道利大鼠模型中肝纤维化的诱导效果更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b31/5838191/a8bd48fb1804/GHFBB-10-S122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b31/5838191/4124d0922043/GHFBB-10-S122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b31/5838191/0208b9744770/GHFBB-10-S122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b31/5838191/a8bd48fb1804/GHFBB-10-S122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b31/5838191/4124d0922043/GHFBB-10-S122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b31/5838191/0208b9744770/GHFBB-10-S122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b31/5838191/a8bd48fb1804/GHFBB-10-S122-g003.jpg

相似文献

1
Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride.用四氯化碳建立实验性肝纤维化疾病动物模型
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S122-S128.
2
Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.马蹄麻叶总黄酮通过调控 TGF-β1/Smad 和 NF-κB 信号通路对四氯化碳诱导的大鼠肝纤维化的保护作用。
J Ethnopharmacol. 2020 May 23;254:112714. doi: 10.1016/j.jep.2020.112714. Epub 2020 Feb 24.
3
Sorafenib Attenuates Fibrotic Hepatic Injury Through Mediating Lysine Crotonylation.索拉非尼通过介导赖氨酸巴豆酰化减轻肝纤维化损伤。
Drug Des Devel Ther. 2022 Jul 3;16:2133-2144. doi: 10.2147/DDDT.S368306. eCollection 2022.
4
Anti-liver fibrosis effect of total flavonoids from Scabiosa comosa Fisch. ex Roem. et Schult. on liver fibrosis in rat models and its proteomics analysis.川西獐牙菜总黄酮抗肝纤维化作用及其蛋白质组学分析。
Ann Palliat Med. 2020 Mar;9(2):272-285. doi: 10.21037/apm.2020.02.29. Epub 2020 Mar 18.
5
Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis.在实验性肝纤维化大鼠模型中,靶向晚期糖基化终末产物受体的特异性小干扰RNA的抗纤维化作用。
Mol Med Rep. 2014 Jul;10(1):306-14. doi: 10.3892/mmr.2014.2207. Epub 2014 May 2.
6
Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats.褪黑素可改善四氯化碳诱导的大鼠实验性肝纤维化。
World J Gastroenterol. 2009 Mar 28;15(12):1452-8. doi: 10.3748/wjg.15.1452.
7
Extracts of Periplaneta americana alleviate hepatic fibrosis by affecting hepatic TGF-β and NF-κB expression in rats with pig serum-induced liver fibrosis.美洲大蠊提取物通过影响猪血清诱导肝纤维化大鼠肝组织 TGF-β和 NF-κB 的表达减轻肝纤维化。
Folia Histochem Cytobiol. 2022;60(2):125-135. doi: 10.5603/FHC.a2022.0011. Epub 2022 May 16.
8
Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway.甘草酸通过 p53 介导的途径减轻 CCl₄诱导的大鼠肝细胞凋亡。
World J Gastroenterol. 2013 Jun 28;19(24):3781-91. doi: 10.3748/wjg.v19.i24.3781.
9
[Mechanism of action of Yiqi Huoxue Recipe in regulating autophagy and reversing liver fibrosis].益气活血方调控自噬及逆转肝纤维化的作用机制
Zhonghua Gan Zang Bing Za Zhi. 2017 May 20;25(5):365-370. doi: 10.3760/cma.j.issn.1007-3418.2017.05.011.
10
[Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].[复合性酒精性肝纤维化小鼠模型的建立及骨桥蛋白和转化生长因子-β1肝脏表达的研究]
Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):207-12.

引用本文的文献

1
M2 Macrophages-Based Immunotherapy: A New Therapeutic Approach in Liver Fibrosis.基于M2巨噬细胞的免疫疗法:肝纤维化的一种新治疗方法。
Adv Pharm Bull. 2025 Jun 2;15(2):314-325. doi: 10.34172/apb.025.43855. eCollection 2025 Jul.
2
The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl-Induced Liver Fibrosis in Rats.基于吡唑并[3,4-d]嘧啶的激酶抑制剂在减轻大鼠四氯化碳诱导的肝纤维化中的作用
Antioxidants (Basel). 2023 Mar 3;12(3):637. doi: 10.3390/antiox12030637.
3
A Novel Sprague-Dawley Rat Model Presents Improved NASH/NAFLD Symptoms with PEG Coated Vitexin Liposomes.

本文引用的文献

1
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.肝纤维化与肝星状细胞:病因、病理特征及治疗靶点
World J Gastroenterol. 2016 Dec 28;22(48):10512-10522. doi: 10.3748/wjg.v22.i48.10512.
2
An experimental model of colitis induced by dextran sulfate sodium from acute progresses to chronicity in C57BL/6: correlation between conditions of mice and the environment.硫酸葡聚糖钠诱导的C57BL/6小鼠结肠炎实验模型从急性发展为慢性:小鼠状况与环境之间的相关性
Gastroenterol Hepatol Bed Bench. 2016 Winter;9(1):45-52.
3
Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-(13)C]pyruvate.
一种新型斯普拉格-道利大鼠模型具有改善的 NASH/NAFLD 症状与 PEG 包被的牡荆素脂质体。
Int J Mol Sci. 2022 Mar 15;23(6):3131. doi: 10.3390/ijms23063131.
使用超极化[1-(13)C]丙酮酸的动态3D代谢成像评估急性四氯化碳模型中的炎症性肝损伤。
NMR Biomed. 2015 Dec;28(12):1671-7. doi: 10.1002/nbm.3431. Epub 2015 Oct 16.
4
Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts.发育过程中和疾病状态下的人肝脏肌成纤维细胞,重点关注门管区(肌)成纤维细胞。
Front Physiol. 2015 Jun 23;6:173. doi: 10.3389/fphys.2015.00173. eCollection 2015.
5
Potential treatment of inflammatory bowel disease: a review of helminths therapy.炎症性肠病的潜在治疗方法:蠕虫疗法综述
Gastroenterol Hepatol Bed Bench. 2014 Winter;7(1):9-16.
6
Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.肝炎小鼠模型:从急性到慢性自身免疫性肝炎
Int J Exp Pathol. 2014 Oct;95(5):309-20. doi: 10.1111/iep.12090. Epub 2014 Aug 12.
7
Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH).非酒精性脂肪性肝炎 (NASH) 的分子机制和新治疗策略。
Int J Mol Sci. 2014 Apr 29;15(5):7352-79. doi: 10.3390/ijms15057352.
8
Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges.胃肠道和肝脏疾病的动物模型。酒精性肝病的动物模型:发病机制、转化相关性和挑战。
Am J Physiol Gastrointest Liver Physiol. 2014 May 15;306(10):G819-23. doi: 10.1152/ajpgi.00041.2014. Epub 2014 Apr 3.
9
Liver fibrosis and repair: immune regulation of wound healing in a solid organ.肝纤维化与修复:实体器官中创伤愈合的免疫调控。
Nat Rev Immunol. 2014 Mar;14(3):181-94. doi: 10.1038/nri3623.
10
Preventive effect of halofuginone on concanavalin A-induced liver fibrosis.常山酮对刀豆蛋白A诱导的肝纤维化的预防作用。
PLoS One. 2013 Dec 16;8(12):e82232. doi: 10.1371/journal.pone.0082232. eCollection 2013.